TY - JOUR
T1 - Familial Male Pseudohermaphroditism without Gynecomastia Due to Deficient Testicular 17-Ketosteroid Reductase Activity
AU - Givens, J. R.
AU - Wiser, W. L.
AU - Summitt, R. L.
AU - Kerber, I. J.
AU - Andersen, R. N.
AU - Pittaway, D. E.
AU - Fish, S. A.
PY - 1974/10/31
Y1 - 1974/10/31
N2 - To evaluate possible 17-ketosteroid reductase deficiency, we studied two sisters with primary amenorrhea, hirsutism, clitoral enlargement and a 46,XY karyotype, who lacked breast development. Plasma luteinizing hormone, follicle-stimulating hormone and urinary 17-ketosteroids were elevated in both subjects. Plasma Δ4-androstenedione was seven to nine times greater than normal, whereas plasma testosterone was low or in the low-normal male range. Spermatic venous plasma of Case 2 contained increased amounts of Δ4-androstenedione and estrone and subnormal amounts of testosterone and estradiol, findings consistent with testicular 17-ketosteroid reductase deficiency. In vitro incubation of testicular tissue of Case 2 confirmed a partial defect in testicular 17-ketosteroid reductase activity and documented increased 3β-hydroxysteroid dehydrogenase activity. Failure of breast development was probably due to lower estrogen levels than in previously reported cases. We conclude that testicular 17-ketosteroid reductase deficiency may cause male pseudohermaphroditism even in the absence of gynecomastia. (N Engl J Med 291:938–944, 1974), CONGENITAL deficiency of testicular enzymes essential for the synthesis of testosterone results in failure of development of normal male genitalia.1 2 3 4 A recently described testicular enzymatic deficiency causing male pseudohermaphroditism concerns 17-ketosteroid reductase (17-KSR), which converts Δ4-androstenedione (A) to testosterone (T) and estrone (E1) to estradiol (E2).5 Breast development has been present in all published cases.5 6 7 8 9 10 The two siblings with defective testicular reduction of A to T did not have breast development. These cases have been previously reported as examples of pseudovaginal perineoscrotal hypospadias.11 Case Histories Two sisters were seen at the ages of 18 (Case.
AB - To evaluate possible 17-ketosteroid reductase deficiency, we studied two sisters with primary amenorrhea, hirsutism, clitoral enlargement and a 46,XY karyotype, who lacked breast development. Plasma luteinizing hormone, follicle-stimulating hormone and urinary 17-ketosteroids were elevated in both subjects. Plasma Δ4-androstenedione was seven to nine times greater than normal, whereas plasma testosterone was low or in the low-normal male range. Spermatic venous plasma of Case 2 contained increased amounts of Δ4-androstenedione and estrone and subnormal amounts of testosterone and estradiol, findings consistent with testicular 17-ketosteroid reductase deficiency. In vitro incubation of testicular tissue of Case 2 confirmed a partial defect in testicular 17-ketosteroid reductase activity and documented increased 3β-hydroxysteroid dehydrogenase activity. Failure of breast development was probably due to lower estrogen levels than in previously reported cases. We conclude that testicular 17-ketosteroid reductase deficiency may cause male pseudohermaphroditism even in the absence of gynecomastia. (N Engl J Med 291:938–944, 1974), CONGENITAL deficiency of testicular enzymes essential for the synthesis of testosterone results in failure of development of normal male genitalia.1 2 3 4 A recently described testicular enzymatic deficiency causing male pseudohermaphroditism concerns 17-ketosteroid reductase (17-KSR), which converts Δ4-androstenedione (A) to testosterone (T) and estrone (E1) to estradiol (E2).5 Breast development has been present in all published cases.5 6 7 8 9 10 The two siblings with defective testicular reduction of A to T did not have breast development. These cases have been previously reported as examples of pseudovaginal perineoscrotal hypospadias.11 Case Histories Two sisters were seen at the ages of 18 (Case.
UR - http://www.scopus.com/inward/record.url?scp=0016293937&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016293937&partnerID=8YFLogxK
U2 - 10.1056/NEJM197410312911805
DO - 10.1056/NEJM197410312911805
M3 - Article
C2 - 4278097
AN - SCOPUS:0016293937
SN - 0028-4793
VL - 291
SP - 938
EP - 944
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 18
ER -